S100A8 and S100A9 expression levels increased in several types of cancer (10), including gastric, colon, pancreatic, bladder, ovarian, thyroid, breast, skin and prostate cancer (8,17–21). This evidence concerns the gene S100A9 and Familial prostate cancer.